British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.

JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, published by PLEIADES PUBLISHING INC, is a pivotal periodical that delves into the intricate relationships between biochemical processes and evolutionary dynamics. With its ISSN 0022-0930 and E-ISSN 1608-3202, this journal serves as a comprehensive platform for researchers, professionals, and students dedicated to understanding the physiological adaptations and biochemical mechanisms influenced by evolutionary pressures. Although it is not an open access journal, it offers valuable insights across its historically significant coverage spanning from 1972 to 2017, making it an essential resource for those working in agricultural, biological, and molecular sciences. Despite its current Scopus rankings revealing limited visibility within its fields, the journal remains committed to fostering scholarly dialogue and advancing knowledge in the realm of evolutionary biochemistry, especially for those exploring the ecological, genetic, and integrative physiological aspects of life.

MOLECULAR PHARMACOLOGY, published by the American Society for Pharmacology and Experimental Therapeutics, is an influential peer-reviewed journal dedicated to advancing the field of pharmacology through comprehensive research on molecular mechanisms of drug action. With an impressive historic convergence from 1965 to 2024, this journal plays a pivotal role in disseminating high-quality research, showcasing significant findings that impact both clinical and experimental pharmacology. Notably, it holds a distinguished Q1 ranking in Pharmacology and a Q2 ranking in Molecular Medicine as of 2023, reflecting its prominence in the academic community. Researchers and practitioners engaged in pharmacological studies will benefit from the journal’s focus on new therapeutic strategies, drug development, and the molecular basis of drug action. While MOLECULAR PHARMACOLOGY is not an open-access journal, it offers a wealth of knowledge behind a subscription model, ensuring that contributors and readers maintain a high standard of academic rigor. Address all inquiries to the editorial office located at 9650 Rockville Pike, Bethesda, MD 20814-3995, United States.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.

Biology-Basel is a premier, peer-reviewed open-access journal published by MDPI since 2012, situated in the heart of Switzerland. With an E-ISSN of 2079-7737, this journal serves as a vital platform for the dissemination of innovative research across the broad spectrum of Agricultural and Biological Sciences, Biochemistry, Genetics, Molecular Biology, and Immunology. Recognized for its rigorous editorial standards and impactful findings, it currently ranks Q1 in Agricultural and Biological Sciences and holds impressive positions in several categories according to the 2023 Scopus rankings. The journal’s open-access model ensures that high-quality research is freely available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Spanning from 2012 to 2024, Biology-Basel is committed to reflecting the latest advancements in biological sciences, making it an essential resource in the ever-evolving landscape of biological research.

MOLECULAR THERAPY, published by CELL PRESS, is a distinguished journal in the field of molecular biology and therapy, renowned for its significant contributions to drug discovery, genetics, and pharmacology since its inception in 2000. This prestigious journal, which holds a commendable position in the Q1 category across multiple disciplines including Drug Discovery, Molecular Medicine, and Molecular Biology, facilitates cutting-edge research and innovative therapies that aim to improve patient outcomes. With an impressive Scopus ranking that places it among the top journals in its field—such as rank #6 in Drug Discovery and #8 in Pharmacology—MOLECULAR THERAPY is crucial for researchers, professionals, and students seeking to advance their understanding and application of molecular techniques. The journal welcomes high-quality submissions that explore the therapeutic potential of molecular mechanisms, fostering a collaborative spirit within the scientific community to push the boundaries of modern medicine.

LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.

JOURNAL OF EXPERIMENTAL BIOLOGY, published by COMPANY BIOLOGISTS LTD, stands as a cornerstone in the fields of Animal Science, Aquatic Science, Ecology, Insect Science, and Physiology. With a rich history dating back to 1945, this esteemed journal has continually provided a platform for high-quality research, evidenced by its impressive Q1 rankings across multiple categories in the 2023 Journal Citation Reports. Located in the United Kingdom, it serves an international audience, offering critical insights and advancements in various biological sciences. As a non-open access journal, it provides rigorous peer-reviewed articles that contribute profoundly to our understanding of biological processes and their implications. With an extensive reach among researchers, practitioners, and academia, the JOURNAL OF EXPERIMENTAL BIOLOGY is not only a repository of knowledge but also a catalyst for ongoing research and innovation in experimental biology.

Physiological Reviews is a prestigious journal published by the American Physiological Society, dedicated to advancing our understanding of physiology across various domains. With an impressive impact factor that places it in Q1 quartiles for medicine, molecular biology, and physiology as of 2023, this journal is recognized as a leading source of high-quality reviews and research analyses. The journal has been a vital resource for the scientific community since its inception in 1945, providing in-depth and comprehensive insights that are crucial for both scholars and practitioners in the field. Although not an open-access publication, it remains widely accessible through institutional subscriptions, ensuring that crucial research findings are disseminated efficiently. With Scopus rankings that place it in the top percentile across multiple categories, Physiological Reviews continues to be an essential platform for the latest advancements and discoveries in physiology, making it indispensable for researchers, professionals, and students alike.

JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY is a distinguished publication presented by the POLISH PHYSIOLOGICAL SOC, dedicated to advancing the fields of physiology and pharmacology. Since its inception in 1991, this journal has maintained a commitment to disseminating vital research findings, contributing to the growing body of knowledge essential for understanding complex biological systems and their interactions with pharmacological agents. With a consistent focus on interdisciplinary studies, the journal holds a Q3 categorization in both Medicine and Pharmacology as well as Physiology for 2023, reflecting its relevance in these crucial fields. Although specific access options are not available, the journal's robust indexing and rankings in Scopus signify its credibility and the high caliber of its contributions, appealing to researchers, professionals, and students alike. Operating from the picturesque Jagiellonian University in Krakow, Poland, this journal not only enriches the academic landscape but also fosters global collaboration and innovation in the life sciences.